- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Nasopharyngeal Cancinoma (NPC) in South Africa
Total 1833 results
-
Fusion Pharmaceuticals Inc.RecruitingGastric Cancer | Colorectal Cancer | Ewing Sarcoma | Squamous Cell Carcinoma of Head and Neck | Pancreatic Ductal Adenocarcinoma (PDAC) | NTSR1 Expressing Solid Tumours | Neuroendocrine Differentiated (NED) Prostate CancerUnited States, Australia
-
Ångstrom PharmaceuticalsCompletedOvarian Cancer | Primary Peritoneal CarcinomaUnited States
-
Medical Research CouncilCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerCanada, United Kingdom, Norway, New Zealand, Netherlands, South Africa, Brazil, Finland
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingUrothelial CarcinomaUnited States, Canada, United Kingdom, Japan, Australia, Argentina, Chile, Israel
-
SCRI Development Innovations, LLCPfizerCompletedSmall Cell Lung CancerUnited States
-
Cell GenesysUnknownCarcinoma, Transitional Cell | Bladder NeoplasmsUnited States, Canada
-
AbbVieCompletedAdvanced Solid Tumors | Squamous Cell Carcinoma of the Head and Neck | Undifferentiated Pleomorphic Sarcoma | Carcinoma of the BreastUnited States, France, Spain
-
Eli Lilly and CompanyGenentech, Inc.Completed
-
SCRI Development Innovations, LLCBayer; NovartisCompletedKidney CancerUnited States
-
National Cancer Institute (NCI)RecruitingLung Adenocarcinoma | Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIC Lung Cancer AJCC v8 | Lung Adenosquamous CarcinomaUnited States
-
UroGen Pharma Ltd.CompletedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Israel
-
Incyte CorporationTerminatedNSCLC (Non-small Cell Lung Carcinoma)United States
-
Ractigen Therapeutics.RecruitingNon-Muscle-Invasive Bladder Cancer (NMIBC)Australia
-
K-Group, Beta, Inc., a wholly owned subsidiary...RecruitingUterine Serous CarcinomaUnited States, Australia, Canada, Georgia
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell CarcinomaPoland, Canada, France, Italy, Spain, United States, Germany, Australia, Netherlands, Japan
-
Genentech, Inc.Approved for marketing
-
Infinity Pharmaceuticals, Inc.Bristol-Myers SquibbCompletedSolid Tumor | Bladder Cancer | Advanced Cancer | Urothelial CarcinomaFrance, Spain, United States, Italy, Czechia, Poland, Serbia
-
BeiGeneRecruitingHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaChina, Italy, Taiwan, Australia, Spain, Korea, Republic of, France, United Kingdom, Thailand, Canada, United States, Georgia, Singapore, Turkey
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Endometrial CarcinomaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma | Advanced Solid Tumors | Metastatic Breast CancerSpain, Belgium, Italy, France, United States, New Zealand, United Kingdom
-
Genentech, Inc.CompletedBasal Cell CarcinomaAustralia, France, United States, Germany, Belgium, United Kingdom
-
Eisai Inc.TerminatedThyroid Carcinoma, AnaplasticItaly, United States, France, Australia, United Kingdom
-
EpimmuneUnknownLung CancerUnited States
-
Regeneron PharmaceuticalsSanofiRecruitingCutaneous Squamous Cell CarcinomaUnited States, Australia, Spain, Germany, Belgium, Italy, France, Japan, United Kingdom, Brazil, Canada, Greece, Ireland, New Zealand, Poland, Russian Federation
-
ImmunoGen, Inc.CompletedSmall Cell Lung CancerUnited States
-
Sesen Bio, Inc.CompletedUrinary Bladder Cancer | Bladder Cancer | Bladder Neoplasms | Bladder TumorsUnited States, Canada
-
Regeneron PharmaceuticalsSuspendedNon-Small Cell Lung Cancer | Triple Negative Breast Cancer | Merkel Cell Carcinoma | Basal Cell Carcinoma | Oropharynx Squamous Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States, Australia
-
MacroGenicsTerminatedHead and Neck Cancer | Head and Neck Neoplasms | Head and Neck Squamous Cell CarcinomaSpain, United States, Australia, Poland, Ukraine, Bulgaria, Hungary
-
National Cancer Institute (NCI)AbbottActive, not recruitingLiver Failure | Melanoma | Renal Failure | Breast Carcinoma | Endometrial Carcinoma | Urothelial Carcinoma | Lung Carcinoma | Ovarian Carcinoma | Esophageal Carcinoma | Metastatic Malignant Neoplasm | Unresectable Malignant Neoplasm | Malignant Head and Neck Neoplasm | Carcinoma of Unknown Primary | Malignant Testicular...United States
-
Novartis PharmaceuticalsTerminatedRecurrent Head and Neck Squamous Cell Carcinoma | Metastatic Head and Neck Squamous Cell CarcinomaFrance, Taiwan, United States, Australia, Canada, Hong Kong, Singapore, Korea, Republic of, Netherlands
-
AstraZenecaCompletedAdvanced Solid Malignancies | Non-Small Cell Lung Cancer (NSCLC) | Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC) | Colorectal Carcinoma (CRC)United States
-
BayerAmgenWithdrawnCarcinoma, HepatocellularUnited States
-
NCIC Clinical Trials GroupSumitomo Pharma Oncology, Inc.CompletedColorectal CarcinomaCanada, Australia, Japan
-
CelgeneCompletedCarcinoma, Non-Small-Cell Lung | Urinary Bladder Neoplasms | Tumor Virus Infections | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Carcinoma, Transitional Cell | Carcinoma, Pancreatic DuctalSpain, United States, France, Netherlands
-
Antiva BiosciencesCompletedCervical Cancer | Cervical Intraepithelial Neoplasia | CIN | Human Papilloma Virus | Cervical Dysplasia | HSIL of Cervix | Cervical Neoplasm | HSIL | High-Grade Squamous Intraepithelial Lesions | High-grade Cervical Intraepithelial NeoplasiaUnited States, Australia
-
Aravive, Inc.TerminatedClear Cell Renal Cell CarcinomaUnited States
-
Regeneron PharmaceuticalsActive, not recruitingBasal Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States, Puerto Rico
-
BioNTech SERecruiting
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedCervical Squamous Cell Carcinoma | Recurrent Cervical CarcinomaUnited States
-
Incyte CorporationTerminatedMetastatic Urothelial Carcinoma | Unresectable Urothelial CarcinomaSpain, France, United States, Italy, Japan, Ireland, Slovakia, Austria, Belgium, Canada, Finland, Germany, Poland, Portugal, Romania, United Kingdom
-
Bristol-Myers SquibbCompletedHepato Cellular Carcinoma (HCC)United States, Argentina, Australia, Belgium, Brazil, Canada, China, Czech Republic, France, Germany, Hong Kong, India, Italy, Japan, Korea, Republic of, Mexico, Poland, Puerto Rico, Russian Federation, South Africa, Spain, Sweden, ... and more
-
University of IowaPatient-Centered Outcomes Research Institute; Medical University of South Carolina and other collaboratorsEnrolling by invitationNeuroendocrine Tumors | Neuroendocrine Carcinoma | Lung Neuroendocrine Neoplasm | Gastroenteropancreatic Neuroendocrine TumorUnited States
-
Nasser Hanna, M.D.Sanofi; Walther Cancer InstituteCompletedNon-Small Cell Lung CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedHER2 Positive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7United States
-
National Cancer Institute (NCI)Active, not recruitingCombined Hepatocellular Carcinoma and Cholangiocarcinoma | Stage III Liver Cancer | Stage IV Liver CancerUnited States
-
Gary MorrowNational Cancer Institute (NCI)CompletedCancer | Fatigue | Breast CarcinomaUnited States
-
Odense University HospitalZealand University Hospital; Rigshospitalet, Denmark; Herlev HospitalRecruitingOvarian Cancer | FrailtyDenmark
-
AstraZenecaApproved for marketingNon Small Cell Lung Cancer (NSCLC)Taiwan, Thailand, Turkey, Brazil, Philippines, Russian Federation, Romania, Austria, Hungary, Bulgaria, Latvia, India, Argentina, Australia, Estonia, Malaysia, Mexico, Singapore, South Africa
-
Bristol-Myers SquibbTerminatedNon-small Cell Lung Cancer (NSCLC)United States, Brazil, Poland, Russian Federation, South Africa, France, Italy, United Kingdom